By Sophie Lindqvist

A new report on the AI-era skincare market has flagged widespread gaps in verifiable product claims, putting fresh pressure on dermatologists to translate label language for patients who arrive armed with chatbot summaries.

The piece, carried by Dermatology Times, summarizes findings that point to a category struggling to substantiate its own marketing at a moment when consumers increasingly research actives through generative search and ingredient-checker apps.

What does the report actually examine?

The headline finding is blunt: claims attached to skincare products are routinely harder to verify than the labels suggest. The editorial framing in Dermatology Times leans on a familiar practitioner concern — that patient questions about "what does this serum actually do" have grown harder to answer with confidence.

Why the timing matters

Three forces are colliding at once. Generative AI search now answers routine skincare queries before a patient ever reaches a clinic. Ingredient transparency rules have tightened in major markets. And social media has accelerated the lifecycle of trending actives faster than the peer-reviewed evidence base can follow.

What does this change for a practicing dermatologist?

It changes the intake conversation. Patients arrive carrying AI summaries, ingredient lists and TikTok citations that may or may not survive a careful read of the back-of-pack INCI panel. Clinicians who used to ask "what are you using" now need to ask "what does the label actually claim."

Where the verifiability gaps tend to live

For clinicians, the practical categories matter more than the marketing language. Three buckets tend to surface in patient questions:

• Efficacy claims — percentage improvements, time-to-result windows, comparator data
• Concentration and formulation claims — percentages of named actives, pH, vehicle specifics
• Tolerance and safety claims — "non-comedogenic," "fragrance-free," dermatologist-tested phrasing

Each carries a different evidence floor, and the report's central message is that those floors are unevenly met across the category.

How to handle it in the room

Dermatologists don't need a new script. They need a sharper filter. The smart move is to ask patients to bring the actual product — the INCI list, not the front-of-pack promise — and walk through it together. That's where the verifiability gaps surface in real time.

It also creates a teachable moment. Not every AI summary is wrong, but not every AI summary is right. The report effectively asks clinicians to treat product claims like a lab value — repeatable, sourced and dated before they accept the number.

What to watch next

Expect three downstream shifts over the coming year. More clinician-authored patient handouts that decode label language. Closer scrutiny of "clinical study" phrasing that lacks citation. And tighter coordination between dermatology societies and regulators on what counts as a substantiated claim in the AI search era.

The skincare aisle is getting louder. The report is, in effect, asking the profession to listen more carefully — and to give patients a way to do the same.